Fig. 3: Inhibition of Foxf2 enhances the differentiation of MSCs into osteoblasts via activation of the canonical Wnt signaling pathway.
From: Foxf2 represses bone formation via Wnt2b/β-catenin signaling

a Gene expression in BMSCs isolated from the Foxf2f/f and Foxf2osp−/− mice by qPCR. Foxf2osp−/− BMSCs showed a significant increase in osteogenic markers. *, P < 0.05 versus the Foxf2f/f mice. b, c, and d RNA-seq data from calvaria of the Foxf2f/f and Foxf2osp−/− mice. b Loss of Foxf2 in osteoprogenitors significantly upregulated the expression of 57 genes while downregulating the expression of 633 genes. c Bar chart of pathways with potentially differentially expressed genes extracted from calvarial bone expression data. The PANTHER server with default parameters for pathway analysis was used for pathway analysis. The length of each bar shows how many genes have been assigned to a given pathway. d There were significant changes in the expression of Wnt2b and Lgr5, which are associated with canonical Wnt signaling. e Gene expression in calvaria bones isolated from the Foxf2f/f and Foxf2osp−/− mice by qPCR. Foxf2osp−/− calvaria showed a significant increase in Wnt2b expression. f WNT2B protein levels in the Foxf2osp−/− mice based on Western blot analysis. Calvaria bones were isolated from the Foxf2f/f (control) or Foxf2osp−/− mice. *, P < 0.05 versus the Foxf2f/f mice. All data represent the mean ± SEM.